A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamides (Q42550068)

2 November 2017

title

A new class of anti-HIV-1 agents targeted toward the nucleocapsid protein NCp7: the 2,2'-dithiobisbenzamides (English)

1 reference

2 November 2017

1 reference

Domagala JM

1

1 reference

2 November 2017

Bader JP

2

1 reference

2 November 2017

Gogliotti RD

3

1 reference

2 November 2017

Sanchez JP

4

1 reference

2 November 2017

Stier MA

5

1 reference

2 November 2017

Song Y

6

1 reference

2 November 2017

Prasad JV

7

1 reference

2 November 2017

Tummino PJ

8

1 reference

2 November 2017

Scholten J

9

1 reference

2 November 2017

Harvey P

10

1 reference

2 November 2017

Holler T

11

1 reference

2 November 2017

Gracheck S

12

1 reference

2 November 2017

Hupe D

13

1 reference

2 November 2017

Rice WG

14

1 reference

2 November 2017

Schultz R

15

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

Bioorganic & Medicinal Chemistry

2 November 2017

published in

1 reference

2 November 2017

volume

5

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

569-579

1 reference

Risking everything? Risk behavior, behavior change, and AIDS.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Nonpolarized Distribution of Glycosylphosphatidylinositols in the Plasma Membrane of Polarized Madin-Darby Canine Kidney Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution‐state structure of the nucleocapsid protein from HIV‐1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Synthesis and antibacterial activity of 2,2'-dithiobis(benzamide) derivatives against Mycobacterium species

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Biophysical characterization of zinc ejection from HIV nucleocapsid protein by anti-HIV 2,2'-dithiobis[benzamides] and benzisothiazolones

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2896%2900269-6

7 January 2021

10.1016/S0968-0896(96)00269-6

Identifiers

DOI

1 reference

2 November 2017

1 reference